
Thermotec
Wearable, flexible, non-invasive ultrasound echo probes.
Date | Investors | Amount | Round |
---|---|---|---|
* | JPY100m | Seed | |
Total Funding | 000k |
Thermotec Inc. is a medical device startup developing wearable and flexible ultrasound echo probes for biosensing. Founded in March 2022 by Masayuki Tanabe, the company originated as a venture from Kumamoto University. The founder and CEO, Masayuki Tanabe, holds a Ph.D. in Engineering and has served as an Assistant Professor at Kumamoto University's Graduate School of Science and Technology and as CTO for CAST Co., Ltd.
The company's core technology addresses the limitations of conventional ultrasound probes, which are often rigid, heavy, and can cause discomfort during use. Thermotec's probes are designed to be thin and flexible, allowing them to conform to the body's curves for comfortable, long-term monitoring without causing pain. This design enables applications such as continuous, at-home monitoring where patients can self-administer scans and receive remote diagnoses from physicians, or constant monitoring of a fetus's condition. The technology is intended to make ultrasound examinations possible in various settings without discomfort, even on bony or intricate parts of the body.
Thermotec's business model focuses on the development and eventual sale of these medical and healthcare devices. The company aims to make ultrasound technology more accessible by creating probes that are not only lighter and thinner but also less expensive than current models. In June 2024, the company secured approximately 100 million yen in funding through a third-party allotment to accelerate the commercialization of its devices. The startup has received several awards and program selections, including the NEDO Entrepreneurs Program (NEP) and certification as a Kumamoto University-launched venture.
Keywords: wearable ultrasound, flexible echo probe, medical device, biosensing, non-invasive monitoring, remote diagnostics, healthcare technology, ultrasound technology, medical imaging, at-home healthcare, continuous monitoring, fetal monitoring, Kumamoto University venture, Masayuki Tanabe, biosensor, medtech